Radiopharmaceuticals with Drs. Sanjay Aneja, Pamela Kunz, and Sylvia Kurz

Yale’s Review of Advances in Oncology: Highlights from the ASCO Annual Meeting | June 26, 2026 Presenters: Sanjay Aneja, MD, PhD, Pamela Kunz, MD, and Sylvia Kurz, MD, PhD Dr. Pamela Kunz explains what theranostics are and how they can be used as a combination approach as a molecularly targeted therapy and diagnostic imaging tool. Dr. Sanjay Aneja shares advances in radioligand therapy for prostate cancer and new research that was presented at ASCO 2026. Dr. Sylvia Kurz shares recent updates in theranostics in neuro-oncology and the radionuclide 177Lu-DOTATE (Lutathera).